BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1504 related articles for article (PubMed ID: 29468564)

  • 1. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    Thygesen C; Metaxas A; Larsen MR; Finsen B
    J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Alzheimer's disease a disorder of mitochondria-associated membranes?
    Schon EA; Area-Gomez E
    J Alzheimers Dis; 2010; 20 Suppl 2():S281-92. PubMed ID: 20421691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.
    Völgyi K; Háden K; Kis V; Gulyássy P; Badics K; Györffy BA; Simor A; Szabó Z; Janáky T; Drahos L; Dobolyi Á; Penke B; Juhász G; Kékesi KA
    Mol Neurobiol; 2017 Apr; 54(3):2060-2078. PubMed ID: 26910821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
    Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
    Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-associated ER membranes in Alzheimer disease.
    Schon EA; Area-Gomez E
    Mol Cell Neurosci; 2013 Jul; 55():26-36. PubMed ID: 22922446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen Sulfide Selectively Inhibits γ-Secretase Activity and Decreases Mitochondrial Aβ Production in Neurons from APP/PS1 Transgenic Mice.
    Zhao FL; Qiao PF; Yan N; Gao D; Liu MJ; Yan Y
    Neurochem Res; 2016 May; 41(5):1145-59. PubMed ID: 26708452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer's disease.
    Aladeokin AC; Akiyama T; Kimura A; Kimura Y; Takahashi-Jitsuki A; Nakamura H; Makihara H; Masukawa D; Nakabayashi J; Hirano H; Nakamura F; Saito T; Saido T; Goshima Y
    Neurobiol Dis; 2019 Dec; 132():104603. PubMed ID: 31494281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
    Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
    J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.